Egg Allergy Market Trends, Growth, Industry & Revenue [2031]

Egg Allergy Market Trends, Growth, Industry & Revenue [2031]

Segments - Egg Allergy Market by Age Groups (Children and Adults), Diagnosis (Skin Test, Blood Test, Food Challenge, and Others), Treatments (Medication and Oral Immunotherapy), End-users (Hospitals & Clinics, Diagnostic Centres, Research Institutes, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4210 | 4.2 Rating | 61 Reviews | 176 Pages | Format : PDF Excel PPT

Report Description


The global egg allergy market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. Egg allergy refers to an immune hypersensitivity to proteins, found in chicken eggs. When the immune system becomes overly sensitive to proteins in egg whites/yolks, an allergy develops. When eggs are swallowed, the body produces chemicals to fight them because they are perceived as a foreign intruder. These chemicals cause the symptoms of an allergic reactions. The symptoms to egg allergies include stomach cramps, vomiting, repetitive cough, tightness in the throat, and shortness of breath. The egg allergy market constitutes various key players in the medical field that launch treatment and diagnosis measures to cure the allergy, which is prevalent in both children and adults.

Egg Allergy Market key takeaways

  • Rising prevalence of egg allergies due to increasing consumption of protein eggs has driven the demand for egg allergy medications in the market.
  • Improved allergy diagnosis and efficiency in the quality of medical services provided has significantly boosted the market.
  • Lack of awareness about new and improved medications and healthcare has restricted the market in developing countries.
  • High cost of medications and treatment are unaffordable by some people which prevents the widespread emergence of the market.
  • Growth of health infrastructure and development of various treatments and medicines to cure allergies is expected to fuel the market.

Scope of the report:

The report on the global egg allergy market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Egg Allergy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Age Groups (Children and Adults), Diagnosis (Skin Test, Blood Test, Food Challenge, and Others), Treatments (Medication and Oral Immunotherapy), End-users (Hospitals & Clinics, Diagnostic Centres, Research Institutes, and Others)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered

Genentech Inc.; Novartis AG.; Pfizer Inc.; Sun Pharmaceutical Industries Ltd.; Bayer AG; Abbott; Astellas Pharma Inc.; Sanofi; Merck & Co. Inc.; and Creative Diagnostic Medicare Pvt. Ltd.

 

Egg Allergy Market Segment Insights:

The children segment is projected to grow significantly during the forecast period

Based on age groups, the egg allergy market can be bifurcated into children and adults. The children segment is projected to grow significantly during the forecast period. Studies show that 70% of children with egg allergies outgrow the condition by the age of 5, with the right treatment and diagnosis. The symptoms for egg allergies in children can range from a mild rash to anaphylaxis. Egg allergies among adults is a rare condition but can be treated with medications or the adult can eat products that are substitutes to eggs.

The skin test segment is projected to hold significant market share

Based on diagnosis, the market can be segmented into skin test, blood test, food challenge and others. The skin test segment is projected to hold significant market share. A skin test is an observational test that allows the doctor to see if the person has had any skin reaction due to the consumption of egg within the first 15 minutes. A blood test measures the body’s immune system’s response to eggs while checking the number of antibodies in the bloodstream that detects an allergic reaction.

Egg Allergy Market by diagnosis

The oral immunotherapy segment is projected to expand at a high CAGR

Based on treatments, the market can be divided into oral immunotherapy and medication. The oral immunotherapy segment is projected to expand at a high CAGR. Oral immunotherapy desensitizes people to egg allergens. This is a safe and effective measure for reducing the allergic reactions. This involves the consumption of small quantity of eggs daily in increasing amounts until a full serving is reached. People who suffer from major reactions due to an egg allergy carry medications like an emergency epinephrine injector to inject this into the blood stream anytime when the body has had a reaction due to the consumption of egg.

The hospitals & clinics segment held substantial market share in 2020

Based on end-users, the market can be segmented into hospitals & clinic, research institutes, diagnostic centers, and others. The hospitals & clinics segment held substantial market share in 2020. The rising awareness of healthcare centers and availability of medical service at hospitals have driven the hospitals and clinics segment. The rising number of skilled doctors and medical staff in hospitals that provide efficient and accurate diagnosis and treatment has shifted preference towards this segment.

 North America dominates the global market

In terms of regions, the global egg allergy market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America constituted a significant share of the market in 2020 due to rising prevalence of egg allergies in the region. Moreover, increasing R&D spending by medical and pharmaceutical companies and growing healthcare infrastructure in the US are driving the market. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing R&D expenditure and government initiatives in the healthcare industry.

Egg Allergy Market by regions

Segments

By Age Groups
  • Children
  • Adults
By Diagnosis
  • Skin Test
  • Blood Test
  • Food Challenge
  • Others
By Treatments
  • Medication
  • Oral Immunotherapy
By End-users
  • Hospitals & Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa
By Key Players
  • Genentech Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Bayer AG
  • Abbott
  • Astellas Pharma Inc.
  • Sanofi
  • Merck & Co. Inc.
  • Creative Diagnostic Medicare Pvt. Ltd.

Competitive Landscape

Key players of the global egg allergy market include Genentech Inc.; Novartis AG.; Pfizer Inc.; Sun Pharmaceutical Industries Ltd.; Bayer AG; Abbott; Astellas Pharma Inc.; Sanofi; Merck & Co. Inc.; and Creative Diagnostic Medicare Pvt. Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Egg Allergy Market by key players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Egg Allergy Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Egg Allergy Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Egg Allergy Market - Supply Chain
  4.5. Global Egg Allergy Market Forecast
     4.5.1. Egg Allergy Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Egg Allergy Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Egg Allergy Market Absolute $ Opportunity
5. Global Egg Allergy Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Egg Allergy Market Size and Volume Forecast by End Users
     5.3.1. Hospitals & Clinics
     5.3.2. Diagnostic Centers
     5.3.3. Research Institutes
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Egg Allergy Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Egg Allergy Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Egg Allergy Demand Share Forecast, 2019-2026
7. North America Egg Allergy Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Egg Allergy Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Egg Allergy Market Size and Volume Forecast by End Users
     7.4.1. Hospitals & Clinics
     7.4.2. Diagnostic Centers
     7.4.3. Research Institutes
     7.4.4. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Egg Allergy Demand Share Forecast, 2019-2026
8. Latin America Egg Allergy Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Egg Allergy Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Egg Allergy Market Size and Volume Forecast by End Users
     8.4.1. Hospitals & Clinics
     8.4.2. Diagnostic Centers
     8.4.3. Research Institutes
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Egg Allergy Demand Share Forecast, 2019-2026
9. Europe Egg Allergy Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Egg Allergy Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Egg Allergy Market Size and Volume Forecast by End Users
     9.4.1. Hospitals & Clinics
     9.4.2. Diagnostic Centers
     9.4.3. Research Institutes
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Egg Allergy Demand Share Forecast, 2019-2026
10. Asia Pacific Egg Allergy Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Egg Allergy Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Egg Allergy Market Size and Volume Forecast by End Users
     10.4.1. Hospitals & Clinics
     10.4.2. Diagnostic Centers
     10.4.3. Research Institutes
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Egg Allergy Demand Share Forecast, 2019-2026
11. Middle East & Africa Egg Allergy Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Egg Allergy Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Egg Allergy Market Size and Volume Forecast by End Users
     11.4.1. Hospitals & Clinics
     11.4.2. Diagnostic Centers
     11.4.3. Research Institutes
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Egg Allergy Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Egg Allergy Market: Market Share Analysis
  12.2. Egg Allergy Distributors and Customers
  12.3. Egg Allergy Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Genentech Inc.
     12.4.2. Novartis AG.
     12.4.3. Pfizer Inc.
     12.4.4. Sun Pharmaceutical Industries Ltd.
     12.4.5. Bayer AG
     12.4.6. Abbott
     12.4.7. Astellas Pharma Inc.
     12.4.8. Sanofi&a

Methodology

Our Clients

Dassault Aviation
sinopec
General Mills
Siemens Healthcare
FedEx Logistics
Microsoft
Nestle SA
Honda Motor Co. Ltd.